← Back to Search

Storytelling for Gout Care Improvement

N/A

Recruiting

Research Sponsored by University of Alabama at Birmingham

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Concomitant rheumatic disease including infectious arthritis, rheumatoid arthritis, or seronegative spondyloarthropathy.

History of specialty care visit for gout (e.g. rheumatology) in the past 2 years

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months

Awards & highlights

Study Summary

This trial aims to improve the care patients with gout receive, both during acute exacerbations and long-term, as well as to enhance participation of minorities in biomedical research in the Deep South.

Who is the study for?

This trial is for adults over 18 with gout who have seen a specialist in the past 2 years and can understand English. It's not for those with less than 6 months to live, recent critical illness or surgery, other rheumatic diseases, or those who've used pegloticase.Check my eligibility

What is being tested?

The study tests a new way to improve care for gout patients in emergency departments using storytelling. It also aims to increase research participation among minorities in the Southeastern U.S., particularly African Americans.See study design

What are the potential side effects?

Since this intervention involves storytelling rather than medication, traditional side effects are not expected. However, participants may experience emotional responses related to discussing their condition.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have a rheumatic condition like rheumatoid arthritis.

Select...

I have seen a specialist for gout in the last 2 years.

Select...

I am over 18 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Outpatient primary care or specialist visits for gout treatment

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment1 Intervention

Storytelling A health literacy-appropriate and culturally-adapted intervention delivered on a tablet computer containing "storytelling" to improve patient gout knowledge and approaches to prevent flares, destigmatize gout, and enhance readiness to adopt available long-term treatments for gout including medications, diet, and exercise, or ii) usual gout care (control state).

Group II: ControlActive Control1 Intervention

Usual Care

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Storytelling

2018

N/A

~240

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Vanderbilt University Medical CenterOTHER

857 Previous Clinical Trials

671,913 Total Patients Enrolled

University of Alabama at BirminghamLead Sponsor

1,590 Previous Clinical Trials

2,281,202 Total Patients Enrolled

4 Trials studying Gout

41,527 Patients Enrolled for Gout

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the sample size for this clinical experiment?

"Affirmative. The details on clinicaltrials.gov demonstrate that this trial is presently enrolling volunteers, with the initial posting taking place on June 1st 2021 and an update to the study occurring in August 12th 2022. 280 participants are needed from one single medical centre."

Answered by AI

Are there any openings in this medical experiment for participants?

"Yes, the information on clinicaltrials.gov confirms that this trial is actively recruiting participants and requires 280 individuals from one location. This study was initially posted to the website on June 1st 2021 and has since been modified as recently as August 12th 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Gout in the ED and Improving Research Participation

Kenneth Saag, MD, MSc 2021. "Gout in the ED and Improving Research Participation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04075903.

All > Gout